(Q41209277)

English

Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases (English)

1 reference

Europe PubMed Central

28 September 2017

neurodegeneration

1 reference

based on heuristic

inferred from title

author name string

Barker R

1

1 reference

Europe PubMed Central

28 September 2017

publication date

1 July 1996

1 reference

Europe PubMed Central

28 September 2017

Reviews in the Neurosciences

1 reference

Europe PubMed Central

28 September 2017

7

1 reference

Europe PubMed Central

28 September 2017

187-214

1 reference

Europe PubMed Central

28 September 2017

3

1 reference

Europe PubMed Central

28 September 2017

Parkinson's disease: pathophysiology

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Selective neurodegeneration in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Genetics and molecular biology of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Marked depletion of dorsal spinal cord substance P and calcitonin gene-related peptide with intact skin flare responses in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P immunoreactivity within neuritic plaques.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P and somatostatin coexist within neuritic plaques: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Fibroblast growth factors: what's in a name?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Preprotachykinin gene expression in the forebrain: regulation by dopamine

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

What, if anything, is a neurotrophic factor?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P and Parkinson's disease: a causal relationship?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P and neurodegenerative disorders. A speculative review

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurogenic inflammation and asthma

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Light microscopic evidence for a substance P-containing innervation of the human nucleus basalis of Meynert

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuropeptides in neurological disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

A detailed examination of substance P in pathologically graded cases of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Detection of epileptiform activity by different noninvasive EEG methods in complex partial epilepsy

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Concepts in Characterization of Tachykinin Receptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Serotonin and substance P coexist in neurons of the rat's central nervous system

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Parkinson's disease: management

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic factors. Switching neurotrophin dependence

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic factors. Neurotrophin autocrine loops

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Behavioural effects of tachykinins and related peptides.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Modulation of the rat mesolimbic dopamine pathway by neurokinins

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Striatal neuropeptide levels in Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuropeptides in Alzheimer type dementia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Human brain substance P: distribution in controls and Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Molecular aspects of the tachykinin receptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Choline acetyltransferase and substance P-like immuno-reactivity in the human spinal cord: changes in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The cellular localization of preprotachykinin A messenger RNA in the bovine nervous system.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on guam in comparison with those in Parkinson's and Alzheimer's diseases

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Studies on the cellular localization of spinal cord substance P receptors.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuropeptides in perspective: the last ten years

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The role of neuropeptides in learning: focus on the neurokinin substance P.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Ontogeny of substance P-containing neuron system of the rat: Immunohistochemical analysis—I. Forebrain and upper brain stem

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Development of substance P (SP)-containing cells in the central nervous system: consequences of neurotransmitter co-localization.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P Counteracts Neurotoxin Damage on Norepinephrine Neurons in Rat Brain During Ontogeny

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Structure and gene organization of bovine neuromedin K precursor

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P and substance P receptor histochemistry in human neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

When did Ray Kennedy's Parkinson's disease begin?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Motor neuron disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Dystrophic peptidergic neurites in senile plaques of Alzheimer's disease hippocampus precede formation of paired helical filaments.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P gene expression in sympathetic neurons is regulated by neuron/support cell interaction.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic factors: from molecule to man.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic factors and synaptic plasticity

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Tachykinin receptors and tachykinin receptor antagonists

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P in the human brain

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P and neuropsychiatric disorders: an overview

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P and the Inflammatory and Immune Response

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The autoradiographic localization of substance P receptors in the rat and bovine spinal cord and the rat and cat spinal trigeminal nucleus pars caudalis and the effects of neonatal capsaicin

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P receptor binding sites are expressed by glia in vivo after neuronal injury

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The nerve growth factor family of receptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Accelerated regeneration of central catecholamine fibers in cat occipital cortex: effects of substance P

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Dissociated cell culture of cholinergic neurons from nucleus basalis of Meynert and other basal forebrain nuclei

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Mammalian Tachykinin Receptors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Stimulatory effects of substance P and nerve growth factor (NGF) on neurite outgrowth in embryonic chick dorsal root ganglia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Stimulatory effects of substance P on neurite extension and cyclic AMP levels in cultured neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Frontal lobe dementia and motor neuron disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Stimulation of connective tissue cell growth by substance P and substance K.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Regional distribution of substance P, neurokinin alpha and neurokinin beta in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Tachykinin-evoked Release of Neurotransmitters from Isolated Spinal Cord of the Newborn Rat

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuronal differentiation factors/cytokines and synaptic plasticity

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Morphological evidence for a substance P projection from medial septum to hippocampus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Differential sensitivity of presumed dopaminergic and non-dopaminergic neurones in rat substantia nigra to electrophoretically applied substance P

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Turning behaviour in animals

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Multiple system atrophy--the nature of the beast

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Autoradiographic distribution of substance P receptors in rat central nervous system

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in the substantia nigra

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Effects of MPTP poisoning on central somatostatin and substance P levels in the mouse.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P receptors are differentially affected in Parkinson's and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Dopamine receptor interactions: some implications for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

DNA damage and chronic neuronal degenerations

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

When more is less: pathogenesis of glutamine repeat neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Ontogeny of substance P-containing neuron system of the rat: Immunohistochemical analysis—II. Lower brain stem

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The detection of preclinical Parkinson's disease: what is the role of positron emission tomography?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic factors: ready to go?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Genetic dissection of Alzheimer disease, a heterogeneous disorder

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Comparison of substance K-like and substance P-like fibers and cells in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem Parkinsonian brains

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic molecules

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Prenatal ontogeny of tyrosine hydroxylase gene expression in the rat ventral mesencephalon.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P raises neuronal membrane excitability by reducing inward rectification.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Increased spontaneous activity following substance P infusion into A10 dopaminergic area

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Behavioural effects of selective tachykinin agonists in midbrain dopamine regions

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

A promising animal model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Substance P immunoreactivity in the post-mortem parkinsonian brain

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The changing scene of neurotrophic factors

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Immunohistochemical quantification of substance P in spinal dorsal horns of patients with multiple system atrophy

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

How trinucleotide repeats may function

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.3.187

21 January 2018

Identifiers

10.1515/REVNEURO.1996.7.3.187

1 reference

Europe PubMed Central

28 September 2017

release_w7vpqteewzgrxl3uqc72tcx6da

1 reference

https://api.fatcat.wiki/v0/release/w7vpqteewzgrxl3uqc72tcx6da

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41209277&oldid=2094319277"